In the past decade,
liquid chromatography-mass spectrometry has undergone rapid development in
clinical laboratory medicine.Benefiting from the high
sensitivity and specificity, as well as the capability of multi-component
analysis in the single run, such
technology is regarded as an excellent alternative to conventional
immunoassays towards
newborn screening for the
genetic diseases,
therapeutic drug monitoring and endocrine
hormones detection.With the continuing progress in expertise-
training,
quality assurance and
methodology standardization, it could be expected that
liquid chromatography-mass spectrometry would become a dynamic and crucial part for routine clinical applications in the near
future.